Literature DB >> 19058927

Evaluation of bacteriophages for prevention and treatment of diarrhea due to experimental enterotoxigenic Escherichia coli O149 infection of pigs.

Nidham Jamalludeen1, Roger P Johnson, Patricia E Shewen, Carlton L Gyles.   

Abstract

The objective of this study was to determine the efficacy of selected phages individually and in combination in prevention and treatment of diarrhea due to experimental O149:H10:F4 enterotoxigenic Escherichia coli (ETEC) in weaned pigs. For prophylaxis, the phages were administered orally shortly after challenge, and for therapeutic use, were given 24h after challenge, following the onset of diarrhea. The parameters used to assess outcomes were weight change, duration of diarrhea, severity of diarrhea, composite diarrhea score, and extent of shedding of the challenge ETEC over 6 days. Six phages that were tested individually in a prophylactic mode were effective as determined by a significant change in each of the parameters, although the phages were not present at titres greater than 10(3)PFU/g of feces. A modified protocol involving pre-treatment of the pigs with florfenicol and oral administration of sodium bicarbonate prior to the ETEC challenge and phage administration resulted in high levels of phages in the feces. Using this protocol, a combination of three phages that was tested in the prophylactic mode significantly reduced the severity of diarrhea and the composite diarrhea score. A mixture of two phages given therapeutically significantly improved each of the outcome parameters, without perturbation of the total fecal E. coli flora. Enumeration of phages in feces after treatment indicated that the phages were replicating to high titres in the intestinal tract of ETEC infected pigs within 1-2 days before declining progressively. These findings indicate that the selected phages were effective in moderating the course of experimental O149:H10:F4 ETEC diarrhea in weaned pigs when given prophylactically or therapeutically.

Entities:  

Mesh:

Year:  2008        PMID: 19058927     DOI: 10.1016/j.vetmic.2008.10.021

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  26 in total

Review 1.  Horizontal gene transfers with or without cell fusions in all categories of the living matter.

Authors:  Joseph G Sinkovics
Journal:  Adv Exp Med Biol       Date:  2011       Impact factor: 2.622

Review 2.  Invited review: strategic adoption of antibiotic-free pork production: the importance of a holistic approach.

Authors:  John F Patience; Alejandro Ramirez
Journal:  Transl Anim Sci       Date:  2022-05-16

Review 3.  Review on Preventive Measures to Reduce Post-Weaning Diarrhoea in Piglets.

Authors:  Nuria Canibe; Ole Højberg; Hanne Kongsted; Darya Vodolazska; Charlotte Lauridsen; Tina Skau Nielsen; Anna A Schönherz
Journal:  Animals (Basel)       Date:  2022-09-27       Impact factor: 3.231

4.  Virulent bacteriophages can target O104:H4 enteroaggregative Escherichia coli in the mouse intestine.

Authors:  Damien Maura; Matthieu Galtier; Chantal Le Bouguénec; Laurent Debarbieux
Journal:  Antimicrob Agents Chemother       Date:  2012-09-24       Impact factor: 5.191

5.  Complete genome sequence of the bacteriophages ECBP1 and ECBP2 isolated from two different Escherichia coli strains.

Authors:  Seong-Won Nho; Mi-Ae Ha; Ki-Sei Kim; Tae-Hwan Kim; Ho-Bin Jang; In-Seok Cha; Seong-Bin Park; Young-Kyu Kim; Tae-Sung Jung
Journal:  J Virol       Date:  2012-11       Impact factor: 5.103

6.  Salmonella Typhimurium-specific bacteriophage ΦSH19 and the origins of species specificity in the Vi01-like phage family.

Authors:  Steven P T Hooton; Andrew R Timms; Joanna Rowsell; Ray Wilson; Ian F Connerton
Journal:  Virol J       Date:  2011-11-02       Impact factor: 4.099

7.  Genomic, proteomic and physiological characterization of a T5-like bacteriophage for control of Shiga toxin-producing Escherichia coli O157:H7.

Authors:  Yan D Niu; Kim Stanford; Andrew M Kropinski; Hans-Wolfgang Ackermann; Roger P Johnson; Yi-Min She; Rafiq Ahmed; Andre Villegas; Tim A McAllister
Journal:  PLoS One       Date:  2012-04-13       Impact factor: 3.240

Review 8.  The factors affecting effectiveness of treatment in phages therapy.

Authors:  Mai Huong Ly-Chatain
Journal:  Front Microbiol       Date:  2014-02-18       Impact factor: 5.640

9.  Effect of bacteriophage supplementation on the growth performance, nutrient digestibility, blood characteristics, and fecal microbial shedding in growing pigs.

Authors:  L Yan; S M Hong; I H Kim
Journal:  Asian-Australas J Anim Sci       Date:  2012-10       Impact factor: 2.509

10.  The use of phage FCL-2 as an alternative to chemotherapy against columnaris disease in aquaculture.

Authors:  Elina Laanto; Jaana K H Bamford; Janne J Ravantti; Lotta-Riina Sundberg
Journal:  Front Microbiol       Date:  2015-08-19       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.